Vorobiof, D A <br/><br/>
Malignant pleural mesothelioma: a phase II trial with docetaxel.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Mar 2002 
 - 412-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdf046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--adverse effects<br/>Carcinoma--drug therapy<br/>Docetaxel<br/>Female<br/>Gastrointestinal Diseases--chemically induced<br/>Hematologic Diseases--chemically induced<br/>Humans<br/>Male<br/>Mesothelioma--drug therapy<br/>Middle Aged<br/>Paclitaxel--adverse effects<br/>Pleural Neoplasms--drug therapy<br/>Survival Rate<br/>Taxoids